Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Santer

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Carcinogenesis|September 11, 2007
Human papillomavirus type 16 E7 oncoprotein inhibits apoptosis mediated by nuclear insulin-like growth factor-binding protein-3 by enhancing its ubiquitin/proteasome-dependent degradationFrédéric R Santer, Barbara Moser, Gilles A Spoden, et al.
Computers and Biomedical Research, an International Journal|June 1, 1991
Kinetics of the multi-step catalytic degradation of a polymer to its constituent subunitsY K Leung, L K Wong, R Santer, et al.
Journal of Virology|November 10, 2006
Identification of the FHL2 transcriptional coactivator as a new functional target of the E7 oncoprotein of human papillomavirus type 16Beatriz Campo-Fernández, Dieter Morandell, Frédéric R Santer, et al.
Endocrine-Related Cancer|March 26, 2010
SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signallingMartin Puhr, Frédéric R Santer, Hannes Neuwirt, et al.
Endocrine-Related Cancer|March 3, 2012
Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathwaysSu Jung Oh, Holger H H Erb, Alfred Hobisch, et al.
Human Mutation|August 3, 2000
Molecular analysis in glycogen storage disease 1 non-A: DHPLC detection of the highly prevalent exon 8 mutations of the G6PT1 gene in German patientsR Santer, J Rischewski, G Block, et al.
Journal of Inherited Metabolic Disease|January 1, 1994
Association of malonyl-CoA decarboxylase deficiency and heterozygote state for haemoglobin C diseaseM B Krawinkel, H D Oldigs, R Santer, et al.
Annals of Clinical Biochemistry|January 1, 1994
Population screening for medium-chain acyl-CoA dehydrogenase deficiency: analysis of medium-chain fatty acids and acylglycines in blood spotsM J Bennett, M C Ragni, R J Ostfeld, et al.
Journal of Inherited Metabolic Disease|August 15, 2006
Bilateral nuclear cataracts as the first neonatal sign of Fanconi-Bickel syndromeF Furlan, R Santer, E Vismara, et al.
Journal of Inherited Metabolic Disease|January 26, 2006
Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type IaC Mühlhausen, R Schneppenheim, U Budde, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Carcinogenesis|September 11, 2007
Human papillomavirus type 16 E7 oncoprotein inhibits apoptosis mediated by nuclear insulin-like growth factor-binding protein-3 by enhancing its ubiquitin/proteasome-dependent degradationFrédéric R Santer, Barbara Moser, Gilles A Spoden, et al.
Computers and Biomedical Research, an International Journal|June 1, 1991
Kinetics of the multi-step catalytic degradation of a polymer to its constituent subunitsY K Leung, L K Wong, R Santer, et al.
Journal of Virology|November 10, 2006
Identification of the FHL2 transcriptional coactivator as a new functional target of the E7 oncoprotein of human papillomavirus type 16Beatriz Campo-Fernández, Dieter Morandell, Frédéric R Santer, et al.
Endocrine-Related Cancer|March 26, 2010
SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signallingMartin Puhr, Frédéric R Santer, Hannes Neuwirt, et al.
Endocrine-Related Cancer|March 3, 2012
Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathwaysSu Jung Oh, Holger H H Erb, Alfred Hobisch, et al.
Human Mutation|August 3, 2000
Molecular analysis in glycogen storage disease 1 non-A: DHPLC detection of the highly prevalent exon 8 mutations of the G6PT1 gene in German patientsR Santer, J Rischewski, G Block, et al.
Journal of Inherited Metabolic Disease|January 1, 1994
Association of malonyl-CoA decarboxylase deficiency and heterozygote state for haemoglobin C diseaseM B Krawinkel, H D Oldigs, R Santer, et al.
Annals of Clinical Biochemistry|January 1, 1994
Population screening for medium-chain acyl-CoA dehydrogenase deficiency: analysis of medium-chain fatty acids and acylglycines in blood spotsM J Bennett, M C Ragni, R J Ostfeld, et al.
Journal of Inherited Metabolic Disease|August 15, 2006
Bilateral nuclear cataracts as the first neonatal sign of Fanconi-Bickel syndromeF Furlan, R Santer, E Vismara, et al.
Journal of Inherited Metabolic Disease|January 26, 2006
Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type IaC Mühlhausen, R Schneppenheim, U Budde, et al.
Pageof 11